1
An Observational Cohort Study of Clinical Outcomes After Antiviral Treatment of Chronic Hepatitis C
Condition(s):Chronic Hepatitis CLast Updated:March 10, 2020Unknown status
Chronic Hepatitis C: 1792 Clinical Trials, Page 1 of 180
Hide Studies Not Open or Pending
2
Observational Cohort Study of Clinical Outcomes After Antiviral Therapy for Chronic Hepatitis C
Condition(s):Chronic Hepatitis CLast Updated:August 28, 2019Unknown status
3
Histologic Changes and Noninvasive Assessment in Hepatitis C Patients Treated With Peginterferon Alpha-2a and Ribavirin
Condition(s):Chronic Hepatitis CLast Updated:March 20, 2020Completed
4
Effects of Genotypes on Interferon Signaling in Chronic Hepatitis C
Condition(s):Chronic Hepatitis CLast Updated:January 12, 2010Terminated
5
Observational Study Evaluating the Quality of Pegylated Interferon Alfa-2a and Ribavirin Treatment for Chronic Hepatitis C in Cooperation With the BNG (Association of German Resident Gastroenterologists)
Condition(s):Chronic Hepatitis CLast Updated:September 23, 2016Completed
6
Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral Drugs
Condition(s):Hepatitis CLast Updated:August 31, 2017Unknown status
7
Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, + Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Romania
Condition(s):Chronic Hepatitis CLast Updated:January 25, 2019Completed
8
Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C
Condition(s):Chronic Hepatitis CLast Updated:December 15, 2014Completed
9
Observational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r – Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation
Condition(s):Chronic Hepatitis C; Genotype 1Last Updated:November 14, 2018Completed
10
Enhancing Access to Care for Chronic Hepatitis C Infected Populations in Hong Kong
Condition(s):Chronic Hepatitis c; Intravenous Drug UsageLast Updated:September 29, 2021Recruiting